Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Interventional × dolasetron × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Neoplasms 1 Nausea 1

Interventions

Dexamethasone 49 Metformin 47 Saline Solution 38 Cyclophosphamide 37 Cytarabine 34 Sodium Chloride 31 Cisplatin 31 Letrozole 29 Bupivacaine 29 Zoledronic Acid 28 Bevacizumab 27 Propofol 26 Carboplatin 26 Docetaxel 25 Dexmedetomidine 25 Vincristine 24 Methotrexate 24 Fluorouracil 24 Fentanyl 24 Capecitabine 23 Doxorubicin 21 Rituximab 20 Prednisone 20 Drug Therapy 20 Paclitaxel 19 Oxaliplatin 19 Morphine 19 Granulocyte Colony-Stimulating Factor 18 Acetaminophen 18 Imiquimod 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡